We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £498,020
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £329,591
Glint is a proprietary multi-currency platform that allows users to buy, save, spend and send real gold and other currencies, digitally with its application. The company asserts that its scalable technology enables its clients to use their currencies such as GBP, USD, EUR and Gold, with Glint's UK, EU and US-issued Mastercards in 210 countries worldwide. Glint also points out that its Peer-to-Peer (P2P) Service, Glint It!, allows clients to send and receive gold and currency between Glint accounts in over 160 countries. The company has raised £20 million in equity funding to date, reached 79,000 registered clients, and overseen over £158 million worth of transactions on its platform. Glint will use the investment to maximise revenue, organically grow its business, increase its registered customer base to 250,000 in 2021, and hire key personnel across various portfolios.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £3,072,539
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,646,249
Lifetise is a financial planning platform that enables prospective clients to plan significant expenditures such as buying a home, marital expenses, child-rearing and retirement. Presently, they have come up with two major offerings: Homefinder and Childminder. The first one acts as a tool that shows money required to afford a home in the UK and the amount of time taken to save the money while the latter helps parents to calculate the costs of childcare along with their work. Lifetise is targeting the 25-40 age group in the UK whose population numbers are approximately 14 million. To date, they have been featured in prominent publications like Evening Standard and Stylist with an active following on Reddit. The company has secured 12,000 customers after their partnering with Accenture's Fintech Accelerator Programme. With the investment, Lifetise will spend more on developing its applications with a focus on all major life expenditures, marketing on social media channels, build partnerships and human resources.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £254,240
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £290,278
AndCo offers an open-source, cost-effective, sustainable solution to co-working by turning hotel lobbies and lavish eateries into co-working spaces all over London. The company has over 90 venues, over 1200 members and over 10 brand partnerships. It has been featured major publications including The Telegraph, Forbes, and The Metro. The funds raised will be used for marketing, development, hiring new teammates and working capital.

Pitch Rated

78%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £269,231
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £286,096
FinOptix is an innovative FinTech company that solves real business problems. FinOptix’s objective is to become a significant player in a rapidly growing FinTech market by developing systems that provide financial clarity to decision-makers. FinOptix has a well-established user base, as well as a sales pipeline that covers multiple geographies and sectors. Their verification and validation procedures applied during the development process and operational trials have led to engagement with commercial partners. With the proceeds, they will design an Evaluator for the future, apply AI techniques to solve complex problems, develop their skill set and framework and hire a team of data scientists based on the assessment.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £125,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph